Cargando…

Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study

BACKGROUND: Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potential interactions among genetic risk for T2D, lifestyle behavior, and metabolic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Jae-Seung, Jung, Sang-Hyuk, Shivakumar, Manu, Xiao, Brenda, Khera, Amit V., Won, Hong-Hee, Kim, Dokyoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284808/
https://www.ncbi.nlm.nih.gov/pubmed/35836215
http://dx.doi.org/10.1186/s12933-022-01560-2
_version_ 1784747644941238272
author Yun, Jae-Seung
Jung, Sang-Hyuk
Shivakumar, Manu
Xiao, Brenda
Khera, Amit V.
Won, Hong-Hee
Kim, Dokyoon
author_facet Yun, Jae-Seung
Jung, Sang-Hyuk
Shivakumar, Manu
Xiao, Brenda
Khera, Amit V.
Won, Hong-Hee
Kim, Dokyoon
author_sort Yun, Jae-Seung
collection PubMed
description BACKGROUND: Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potential interactions among genetic risk for T2D, lifestyle behavior, and metabolic risk factors with CVD. METHODS: A total of 345,217 unrelated participants of white British descent were included in analyses. Genetic risk for T2D was estimated as a genome-wide polygenic risk score constructed from > 6 million genetic variants. A favorable lifestyle was defined in terms of four modifiable lifestyle components, and metabolic health status was determined according to the presence of metabolic syndrome components. RESULTS: During a median follow-up of 8.9 years, 21,865 CVD cases (6.3%) were identified. Compared with the low genetic risk group, participants at high genetic risk for T2D had higher rates of overall CVD events, CVD subtypes (coronary artery disease, peripheral artery disease, heart failure, and atrial fibrillation/flutter), and CVD mortality. Individuals at very high genetic risk for T2D had a 35% higher risk of CVD than those with low genetic risk (HR 1.35 [95% CI 1.19 to 1.53]). A significant gradient of increased CVD risk was observed across genetic risk, lifestyle, and metabolic health status (P for trend > 0.001). Those with favorable lifestyle and metabolically healthy status had significantly reduced risk of CVD events regardless of T2D genetic risk. This risk reduction was more apparent in young participants (≤ 50 years). CONCLUSIONS: Genetic risk for T2D was associated with increased risks of overall CVD, various CVD subtypes, and fatal CVD. Engaging in a healthy lifestyle and maintaining metabolic health may reduce subsequent risk of CVD regardless of genetic risk for T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01560-2.
format Online
Article
Text
id pubmed-9284808
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92848082022-07-16 Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study Yun, Jae-Seung Jung, Sang-Hyuk Shivakumar, Manu Xiao, Brenda Khera, Amit V. Won, Hong-Hee Kim, Dokyoon Cardiovasc Diabetol Research BACKGROUND: Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potential interactions among genetic risk for T2D, lifestyle behavior, and metabolic risk factors with CVD. METHODS: A total of 345,217 unrelated participants of white British descent were included in analyses. Genetic risk for T2D was estimated as a genome-wide polygenic risk score constructed from > 6 million genetic variants. A favorable lifestyle was defined in terms of four modifiable lifestyle components, and metabolic health status was determined according to the presence of metabolic syndrome components. RESULTS: During a median follow-up of 8.9 years, 21,865 CVD cases (6.3%) were identified. Compared with the low genetic risk group, participants at high genetic risk for T2D had higher rates of overall CVD events, CVD subtypes (coronary artery disease, peripheral artery disease, heart failure, and atrial fibrillation/flutter), and CVD mortality. Individuals at very high genetic risk for T2D had a 35% higher risk of CVD than those with low genetic risk (HR 1.35 [95% CI 1.19 to 1.53]). A significant gradient of increased CVD risk was observed across genetic risk, lifestyle, and metabolic health status (P for trend > 0.001). Those with favorable lifestyle and metabolically healthy status had significantly reduced risk of CVD events regardless of T2D genetic risk. This risk reduction was more apparent in young participants (≤ 50 years). CONCLUSIONS: Genetic risk for T2D was associated with increased risks of overall CVD, various CVD subtypes, and fatal CVD. Engaging in a healthy lifestyle and maintaining metabolic health may reduce subsequent risk of CVD regardless of genetic risk for T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01560-2. BioMed Central 2022-07-14 /pmc/articles/PMC9284808/ /pubmed/35836215 http://dx.doi.org/10.1186/s12933-022-01560-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yun, Jae-Seung
Jung, Sang-Hyuk
Shivakumar, Manu
Xiao, Brenda
Khera, Amit V.
Won, Hong-Hee
Kim, Dokyoon
Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_full Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_fullStr Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_full_unstemmed Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_short Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_sort polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective uk biobank study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284808/
https://www.ncbi.nlm.nih.gov/pubmed/35836215
http://dx.doi.org/10.1186/s12933-022-01560-2
work_keys_str_mv AT yunjaeseung polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT jungsanghyuk polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT shivakumarmanu polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT xiaobrenda polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT kheraamitv polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT wonhonghee polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT kimdokyoon polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy